Résumé
This document provides guidance to manufacturers on the minimal considerations for in vitro diagnostic (IVD) medical devices in a public health crisis: - general considerations; - risk reduction; - monitoring the devices’ post-market performance and quality assurance; - implementing a communication system. This document does not supersede the existing traditional regulatory authorization requirements for IVD medical devices available in the marketplace.
Informations générales
-
État actuel: ProjetStade: Epreuve envoyée au secrétariat ou mise au vote du FDIS: 8 semaines [50.20]
-
Edition: 1
-
Comité technique :ISO/TC 212ICS :11.100.10
- RSS mises à jour